Utility of Contrast-Enhanced FDG-PET/CT in the Clinical Management of Pancreatic Cancer - Concepedia

Concepedia

Publication | Closed Access

Utility of Contrast-Enhanced FDG-PET/CT in the Clinical Management of Pancreatic Cancer

129

Citations

18

References

2012

Year

Akinori Asagi, Koji Ohta, Junichirou Nasu, Minoru Tanada, Seijin Nadano, Rieko Nishimura, Norihiro Teramoto, Kazuhide Yamamoto, Takeshi Inoue, Haruo Iguchi

Abstract

Positron emission tomography/CE-CT is useful for the clinical management of pancreatic cancer.

References

	Year	Citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, JNCI Journal of the National Cancer Institute World Health OrganizationSolid TumorsCancer ManagementMetronomic ChemotherapyResponse Assessment	2000	15.7K
Cancer Statistics, 2010 Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu, CA A Cancer Journal for Clinicians	2010	12.6K
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Howard A. Burris, Malcolm J. Moore, John Sahl Andersen, Journal of Clinical Oncology	1997	5.8K
Prognostic indicators for survival after resection of pancreatic adenocarcinoma R. Geer, Murray F. Brennan The American Journal of Surgery Surgical OncologyPancreatic CancerMedicinePrognostic IndicatorsPrognosis	1993	764
Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal Kazuichi Okazaki, Shigeyuki Kawa, Terumi Kamisawa, Journal of Gastroenterology	2006	585
Surgery for Recurrent Colon Cancer: Strategies for Identifying Resectable Recurrence and Success Rates after Resection Richard M. Goldberg Annals of Internal Medicine	1998	268
Delayed18F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas Yuji Nakamoto, Tatsuya Higashi, Harumi Sakahara, Cancer	2000	227
Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. Dominique Delbeke, David M. Rose, William C. Chapman, PubMed	1999	225
Fluorine-18 fluorodeoxyglucose positron mission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases Michael Zimny, Roland Bares, J�rgen Fa�, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyPancreatic CancerMedical ImagingPancreatic Fluid CollectionDifferential Diagnosis	1997	199
A late phase II study of S-1 for metastatic pancreatic cancer Takuji Okusaka, Akihiro Funakoshi, Junji Furuse, Cancer Chemotherapy and Pharmacology Pancreatic CancerGastrointestinal OncologyMedicinePathologyMetastatic Pancreatic Cancer	2007	169

Page 1